細胞健康篩檢市場規模、佔有率、成長分析、按測試、按樣本、按收集、按地區 - 行業預測，2024-2031 年

2022年全球細胞健康篩檢市場規模為26.5億美元，從2023年的29.3億美元成長到2031年的65.1億美元，預計在預測期間（2024-2031年）成長。 。

由於醫療保健技術的進步和對預防醫學的日益重視，預計全球細胞健康篩檢市場將顯著成長。該市場利用創新的診斷工具來評估氧化壓力、粒線體功能、發炎和 DNA 損傷等關鍵細胞參數，從而實現慢性疾病和潛在健康風險的早期檢測。生活方式相關疾病發生率的增加和人口老化是推動這些服務需求的主要因素。此外，個人化醫療的發展以及對細胞健康如何影響整體健康的更深入了解正在進一步推動市場擴張。隨著預防性醫療保健意識的增強，消費者對細胞健康篩檢的興趣也隨之增強，儘管存在監管挑戰，但仍刺激了技術投資和提供者之間的競爭。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

細胞健康篩檢市場規模：按測試和複合年成長率（2024-2031）

• 市場概況
• 單一測試板
  • 端粒測試
  • 氧化壓力測試
  • 發炎測試
  • 重金屬測試
• 多測試板

細胞健康篩檢市場規模：依樣本及複合年成長率（2024-2031）

• 市場概況
• 血
• 唾液
• 血清
• 尿

細胞健康篩檢市場規模：按收集和複合年成長率（2024-2031）

• 市場概況
• 某人的家
• 辦公室
• 醫院
• 診斷實驗室

細胞健康篩檢市場規模：按地區和複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Genova Diagnostics（USA）
• Telomere Diagnostics（USA）
• Life Length（Spain）
• Quest Diagnostics（USA）
• Repeat Diagnostics（Canada）
• SpectraCell Laboratories（USA）
• Zimetry LLC（USA）
• Cell Science Systems（USA）
• Titanovo, Inc.（USA）
• Segterra, Inc.（USA）
• LabCorp Holdings（USA）
• BioReference Laboratories（USA）
• Immundiagnostik AG（Germany）
• DNA Labs（India）
• Cleveland HeartLab, Inc.（USA）
• Thriva（UK）
• Everlywell（USA）
• InsideTracker（USA）
• Viome（USA）
• SelfDecode（USA）

結論和建議

Global Cellular Health Screening Market size was valued at USD 2.65 billion in 2022 and is poised to grow from USD 2.93 billion in 2023 to USD 6.51 billion by 2031, growing at a CAGR of 10.5% during the forecast period (2024-2031).

The Global Cellular Health Screening Market is poised for significant growth, driven by healthcare technology advancements and a heightened emphasis on preventive care. This market leverages innovative diagnostic tools to evaluate key cellular parameters-such as oxidative stress, mitochondrial function, inflammation, and DNA damage-enabling the early detection of chronic diseases and potential health risks. The rising incidence of lifestyle-related disorders and an aging population are key factors propelling demand for these services. Additionally, the movement towards personalized medicine and a deeper comprehension of cellular health's impact on overall wellness are further fueling market expansion. As awareness of preventive healthcare increases, consumer interest in cellular health screening rises, motivating investments in technology and competition among providers, despite existing regulatory challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cellular Health Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cellular Health Screening Market Segmental Analysis

Global Cellular Health Screening Market is segmented by test, sample, collection and region. Based on test, the market is segmented into single test panels and multi-test panels. Based on sample, the market is segmented into blood, saliva, serum and urine. Based on collection, the market is segmented into home, office, hospital and diagnostic labs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cellular Health Screening Market

The Global Cellular Health Screening Market is significantly influenced by the rising incidence of chronic diseases across the globe. Conditions such as diabetes, cardiovascular ailments, and cancer are becoming increasingly common, driving the demand for early detection and preventive healthcare solutions. Cellular health screening provides critical information regarding individual cell functionality and associated health risks, making it an essential resource for the timely identification and management of chronic illnesses. This growing need for proactive health monitoring and intervention underscores the importance of cellular health screening as a vital component in modern healthcare strategies aimed at combating the escalating burden of chronic diseases.

Restraints in the Global Cellular Health Screening Market

A significant limitation in the Global Cellular Health Screening Market is the high expense linked to advanced screening technologies and tests. Despite the rising demand for cellular health services, the financial requirements for developing and applying innovative diagnostic tools, along with conducting thorough health assessments, remain considerable. Such high costs can restrict access to cellular health screening for certain individuals and healthcare providers, particularly in areas with limited resources, ultimately impeding market growth. Therefore, initiatives aimed at reducing these costs and enhancing accessibility are crucial for overcoming this challenge and expanding the market's influence.

Market Trends of the Global Cellular Health Screening Market

The Global Cellular Health Screening market is witnessing a significant trend driven by the increasing adoption of mobile health (mHealth) solutions and technology. As mobile devices become more sophisticated and connectivity improves, stakeholders are turning to mHealth tools for efficient cellular health diagnostics and screening. These technologies provide convenient access to services, enabling remote monitoring of cellular health metrics and facilitating seamless communication between patients and healthcare providers. This emphasis on mHealth not only enhances the efficiency and accessibility of screening services but also significantly improves the overall patient experience, propelling the evolution and growth of the cellular health screening market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cellular Health Screening Market Size by Test & CAGR (2024-2031)

• Market Overview
• Single Test Panels
  • Telomere Tests
  • Oxidative Stress Tests
  • Inflammation Tests
  • Heavy Metals Tests
• Multi-Test Panels

Global Cellular Health Screening Market Size by Sample & CAGR (2024-2031)

• Market Overview
• Blood
• Saliva
• Serum
• Urine

Global Cellular Health Screening Market Size by Collection & CAGR (2024-2031)

• Market Overview
• Home
• Office
• Hospital
• Diagnostic Labs

Global Cellular Health Screening Market Size & CAGR (2024-2031)

• North America (Test, Sample, Collection)
  • USA
  • Canada
• Europe (Test, Sample, Collection)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test, Sample, Collection)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test, Sample, Collection)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test, Sample, Collection)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Genova Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Telomere Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Life Length (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Repeat Diagnostics (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SpectraCell Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimetry LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Science Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Titanovo, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Segterra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp Holdings (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioReference Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immundiagnostik AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNA Labs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland HeartLab, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thriva (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Everlywell (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InsideTracker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viome (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SelfDecode (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations